Publications

Publications published since 2005 from OUS - Dept. of Gastroenterology (Div Medicine)

463 publications found

Publications 2024

1. Andersen V, Pingel J, Søfelt HL, Hikmat Z, Johansson M, Pedersen VS, Bertelsen B, Carlsson A, Lindh M, Svavarsdóttir E, Repsilber D, Joergensen MT, Christensen R, Fejrskov A, Füchtbauer JD, Kjeldsen J, Jensen MD, Aalykke C, Rejler M, Høivik ML, Davidsdottir L, Carlson M, Halfvarson J, Zachariassen HH, Petersen LB et al. (2024)
   Sex and gender in inflammatory bowel disease outcomes and research
   Lancet Gastroenterol Hepatol, 9 (11), 1041-1051
   DOI 10.1016/S2468-1253(24)00159-6, PubMed 39395438
2. Anisdahl K, Lirhus SS, Medhus AW, Moum B, Melberg HO, Høivik ML (2024)
   Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study
   Dig Liver Dis, 56 (9), 1503-1510
   DOI 10.1016/j.dld.2024.02.002, PubMed 38433021
3. Druckrey-Fiskaaen KT, Vold JH, Madebo T, Midgard H, Dalgard O, Leiva RA, Fadnes LT, INTRO-HCV Study Group (2024)
   Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study
   Subst Abuse Treat Prev Policy, 19 (1), 21
   DOI 10.1186/s13011-024-00603-z, PubMed 38532435
4. Fejrskov A, Füchtbauer JD, Davíðsdóttir LG, Halfvarson J, Høivik ML, Jensen MD, Mortensen JH, Nielsen LN, Rejler M, Repsilber D, Söderholm JD, Aalykke C, Andersen V, Christensen R, Kjeldsen J (2024)
   Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT)
   BMJ Open, 14 (5), e083144
   DOI 10.1136/bmjopen-2023-083144, PubMed 38754881
5. Holten KA, Bernklev T, Opheim R, Olsen BC, Detlie TE, Strande V, Ricanek P, Boyar R, Bengtson MB, Aabrekk TB, Asak Ø, Frigstad SO, Kristensen VA, Hagen M, Henriksen M, Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP (2024)
   Fatigue in patients with inflammatory bowel disease in remission one year after diagnosis (the IBSEN III study)
   J Crohns Colitis (in press)
   DOI 10.1093/ecco-jcc/jjae170, PubMed 39527064
6. Johannessen A, Midgard H (2024)
   [Not Available]
   Tidsskr Nor Laegeforen, 144 (9)
   DOI 10.4045/tidsskr.24.0365, PubMed 39166991
7. Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten AK, Dalgard O, Midgard H (2024)
   Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial
   Viruses, 16 (6)
   DOI 10.3390/v16060858, PubMed 38932151
8. Maurud S, Lunde L, Moen A, Opheim R (2024)
   Exploring the foundations of a digital health information service for patients with inflammatory bowel disease: a mixed method study in Gravitate-Health
   BMC Gastroenterol, 24 (1), 184
   DOI 10.1186/s12876-024-03272-1, PubMed 38789953
9. Midgard H, Malme KB, Finbråten AK, Dalgard O (2024)
   Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins?
   Clin Infect Dis (in press)
   DOI 10.1093/cid/ciae298, PubMed 38824443
10. Midgard H, Malme KB, Pihl CM, Berg-Pedersen RM, Tanum L, Klundby I, Haug A, Tveter I, Bjørnestad R, Olsen IC, Finbråten AK, Dalgard O (2024)
    Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial
    Clin Infect Dis, 78 (3), 582-590
    DOI 10.1093/cid/ciad711, PubMed 37992203
11. Salihovic S, Nyström N, Mathisen CB, Kruse R, Olbjørn C, Andersen S, Noble AJ, Dorn-Rasmussen M, Bazov I, Perminow G, Opheim R, Detlie TE, Huppertz-Hauss G, Hedin CRH, Carlson M, Öhman L, Magnusson MK, Keita ÅV, Söderholm JD, D'Amato M, Orešič M, Wewer V, Satsangi J, Lindqvist CM, Burisch J et al. (2024)
    Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease
    Nat Commun, 15 (1), 4567
    DOI 10.1038/s41467-024-48763-7, PubMed 38830848
12. Strande V, Høivik ML, Kristensen VA (2024)
    Letter: Critical appraisal of biologic therapy in early ulcerative colitis management-Addressing study limitations and the role of psychological resilience-Authors' reply
    Aliment Pharmacol Ther, 60 (6), 831-832
    DOI 10.1111/apt.18187, PubMed 39072820
13. Strande V, Lund C, Hagen M, Bengtson MB, Cetinkaya RB, Detlie TE, Frigstad SO, Høie O, Medhus AW, Henriksen M, Aass Holten KI, Hovde Ø, Huppertz-Hauss G, Johansen I, Olsen BC, Opheim R, Ricanek P, Torp R, Tønnessen T, Vatn S, Aabrekk TB, Høivik ML, Kristensen VA (2024)
    Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort
    Aliment Pharmacol Ther, 60 (3), 357-368
    DOI 10.1111/apt.18097, PubMed 38837289
14. Whittaker R, Midgard H, Dalgard O, Kløvstad H (2024)
    Treatment uptake among notified cases of hepatitis C virus infection in Norway, 1990 to 2022: a registry-based study to monitor progress towards elimination
    Euro Surveill, 29 (46)
    DOI 10.2807/1560-7917.ES.2024.29.46.2400180, PubMed 39544147
15. Wiken TH, Høivik ML, Anisdahl K, Buer L, Warren DJ, Bolstad N, Hagen M, Moum BA, Medhus AW (2024)
    Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study
    Crohns Colitis 360, 6 (1), otae013
    DOI 10.1093/crocol/otae013, PubMed 38544907
16. Zerouga I, Valeur J, Sommer C, Cvancarova Småstuen M, Medhus AW, Lund C, Johansen I, Cetinkaya RB, Bengtson MB, Torp R, Hovde Ø, Huppertz-Hauss G, Detlie TE, Aabrekk TB, Ricanek P, Frigstad SO, Hopstock LA, Opheim R, Kristensen VA, Høivik ML, Hauger Carlsen M, Aas AM (2024)
    Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study
    Scand J Gastroenterol, 59 (6), 652-660
    DOI 10.1080/00365521.2024.2313056, PubMed 38356408

Publications 2023

1. Ali S, Jha D, Ghatwary N, Realdon S, Cannizzaro R, Salem OE, Lamarque D, Daul C, Riegler MA, Anonsen KV, Petlund A, Halvorsen P, Rittscher J, de Lange T, East JE (2023)
   A multi-centre polyp detection and segmentation dataset for generalisability assessment
   Sci Data, 10 (1), 75
   DOI 10.1038/s41597-023-01981-y, PubMed 36746950
2. Andersen IM, Reims HM, Grzyb K, Fevang B, Melum E, Aukrust P, Wiencke K, Nordøy I, Line PD, Jørgensen SF (2023)
   Long-term survival after liver transplantation in patients with common variable immunodeficiency
   Liver Transpl, 29 (8), 894-899
   DOI 10.1097/LVT.0000000000000130, PubMed 36932715
3. Braadland PR, Bergquist A, Kummen M, Bossen L, Engesæter LK, Reims HM, Björk I, Grzyb K, Abildgaard A, Småstuen MC, Folseraas T, Trøseid M, Ulvik A, Ueland PM, Melum E, Line PD, Høivik ML, Grønbæk H, Karlsen TH, Vesterhus M, Hov JR (2023)
   Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
   J Hepatol, 79 (4), 955-966
   DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
4. Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein CN, Kaplan GG, Duricova D, Greenberg D, Melberg HO, Watanabe M, Ahn HS, Targownik L, Pittet VEH, Annese V, Park KT, Katsanos KH, Høivik ML, Krznaric Z, Chaparro M, Loftus EV, Lakatos PL, Gisbert JP, Bemelman W, Moum B et al. (2023)
   The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
   Lancet Gastroenterol Hepatol, 8 (5), 458-492
   DOI 10.1016/S2468-1253(23)00003-1, PubMed 36871566
5. Ecklu-Mensah G, Choo-Kang C, Maseng MG, Donato S, Bovet P, Viswanathan B, Bedu-Addo K, Plange-Rhule J, Oti Boateng P, Forrester TE, Williams M, Lambert EV, Rae D, Sinyanya N, Luke A, Layden BT, O'Keefe S, Gilbert JA, Dugas LR (2023)
   Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study
   Nat Commun, 14 (1), 5160
   DOI 10.1038/s41467-023-40874-x, PubMed 37620311
6. Evensen H, Sandstad O, Larssen L, Hagen M, Kristensen VA, Søvik TT, Schulz A, Hauge T, Medhus AW (2023)
   Intraoperative distensibility measurement in POEM for achalasia: impact on patient outcome and associations with other outcome variables at 1-year follow-up
   Surg Endosc, 37 (12), 9283-9290
   DOI 10.1007/s00464-023-10494-z, PubMed 37880446
7. Follin-Arbelet B, Cvancarova Småstuen M, Hovde Ø, Jelsness-Jørgensen LP, Moum B (2023)
   Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)
   J Crohns Colitis, 17 (4), 497-503
   DOI 10.1093/ecco-jcc/jjac156, PubMed 36239614
8. Follin-Arbelet B, Cvancarova Småstuen M, Hovde Ø, Jelsness-Jørgensen LP, Moum B (2023)
   Risk of Cancer in Patients With Crohn's Disease 30 Years After Diagnosis (the IBSEN Study)
   Crohns Colitis 360, 5 (4), otad057
   DOI 10.1093/crocol/otad057, PubMed 37886706
9. Follin-Arbelet B, Småstuen MC, Hovde Ø, Jelsness-Jørgensen LP, Moum B (2023)
   Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study)
   Scand J Gastroenterol, 58 (11), 1264-1270
   DOI 10.1080/00365521.2023.2223709, PubMed 37337889
10. Fossmark R, Lirhus SS, Høivik ML (2023)
    The impact of proton pump inhibitors on the course of ulcerative colitis: a cohort study of over 10,000 newly diagnosed patients in Norway
    Scand J Gastroenterol, 59 (1), 46-51
    DOI 10.1080/00365521.2023.2255710, PubMed 37681998
11. Haukeland JW, Vesterhus MN, Jørgensen KK, Frigstad SO, Karlsen TH (2023)
    [The FIB-4 test as a decision-making tool]
    Tidsskr Nor Laegeforen, 143 (5)
    DOI 10.4045/tidsskr.23.0176, PubMed 36987901
12. Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
    A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
    Hepatology, 77 (3), 715-728
    DOI 10.1002/hep.32773, PubMed 36056902
13. Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
    Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
    Hepatology, 77 (6), E188-E189
    DOI 10.1097/HEP.0000000000000340, PubMed 36815351
14. Holten KIA, Bernklev T, Opheim R, Johansen I, Olsen BC, Lund C, Strande V, Medhus AW, Perminow G, Bengtson MB, Cetinkaya RB, Vatn S, Frigstad SO, Aabrekk TB, Detlie TE, Hovde Ø, Kristensen VA, Småstuen MC, Henriksen M, Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP (2023)
    Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study
    J Crohns Colitis, 17 (11), 1781-1790
    DOI 10.1093/ecco-jcc/jjad094, PubMed 37279652
15. Horrigan JM, Louis E, Spinelli A, Travis S, Moum B, Salwen-Deremer J, Halfvarson J, Panaccione R, Dubinsky MC, Munkholm P, Siegel CA (2023)
    The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease
    Crohns Colitis 360, 5 (2), otad006
    DOI 10.1093/crocol/otad006, PubMed 36937140
16. Johansen I, Småstuen MC, Løkkeberg ST, Kristensen VA, Høivik ML, Lund C, Olsen B, Strande V, Huppertz-Hauss G, Aabrekk TB, Bengtson MB, Ricanek P, Detlie TE, Frigstad SO, Jelsness-Jørgensen LP, Opheim R (2023)
    Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
    BMC Gastroenterol, 23 (1), 255
    DOI 10.1186/s12876-023-02889-y, PubMed 37501083
17. Juul FE, Hov JER, Trøseid M, Johnsen PH, Valeur J (2023)
    [Gut microbiota and intestinal disease –a sober warning]
    Tidsskr Nor Laegeforen, 143 (10)
    DOI 10.4045/tidsskr.23.0121, PubMed 37376933
18. Jørgensen KK, Høivik ML, Chopra A, Benth JŠ, Ricanek P, Moum PB, Jyssum I, Bolstad N, Warren DJ, Vaage PJT, Munthe PLA, Lundin PKEA, Anisdahl K, Syversen SW, Goll GL, Lund-Johansen F, Medhus AW, Jahnsen PJ (2023)
    Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type
    Scand J Gastroenterol, 58 (8), 874-882
    DOI 10.1080/00365521.2023.2177884, PubMed 36788656
19. Lindemann K, Heimisdottir Danbolt S, Ramberg L, Eyjólfsdóttir B, Wang YY, Heli-Haugestøl AG, Walcott SL, Mjåland O, Navestad GA, Hermanrud S, Juul-Hansen KE, Bragstad LK, Opheim R, Kleppe A, Kongsgaard U (2023)
    Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patients
    Int J Gynecol Cancer, 33 (8), 1287-1294
    DOI 10.1136/ijgc-2023-004356, PubMed 37451689
20. Malme KB, Ulstein K, Finbråten AK, Wüsthoff LEC, Kielland KB, Hauge J, Dalgard O, Midgard H (2023)
    Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study
    Int J Drug Policy, 116, 104044
    DOI 10.1016/j.drugpo.2023.104044, PubMed 37149914
21. Mikalsen IM, Breder S, Medhus AW, Folseraas T, Aabakken L, Ånonsen KV (2023)
    ERCP for the initial management of malignant biliary obstruction - real world data on 596 procedures
    Scand J Gastroenterol, 59 (3), 369-377
    DOI 10.1080/00365521.2023.2282375, PubMed 37994406
22. Olsen BC, Opheim R, Kristensen VA, Høivik ML, Lund C, Aabrekk TB, Johansen I, Holten K, Strande V, Bengtson MB, Ricanek P, Detlie TE, Bernklev T, Jelsness-Jørgensen LP, Huppertz-Hauss G (2023)
    Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)
    Qual Life Res, 32 (10), 2951-2964
    DOI 10.1007/s11136-023-03435-9, PubMed 37219727
23. Opheim E, Dalgard O, Ulstein K, Sørli H, Backe Ø, Foshaug T, Couëssurel Wüsthoff LE, Midgard H (2023)
    Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs
    Int J Drug Policy, 123, 104279
    DOI 10.1016/j.drugpo.2023.104279, PubMed 38061225
24. Polaris Observatory Collaborators (2023)
    Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
    Lancet Gastroenterol Hepatol, 8 (10), 879-907
    DOI 10.1016/S2468-1253(23)00197-8, PubMed 37517414
25. Svanevik M, Lorentzen J, Borgeraas H, Sandbu R, Seip B, Medhus AW, Hertel JK, Kolotkin RL, Småstuen MC, Hofsø D, Hjelmesæth J (2023)
    Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial
    Lancet Diabetes Endocrinol, 11 (8), 555-566
    DOI 10.1016/S2213-8587(23)00127-4, PubMed 37414071
26. Svendsen EJ, Opheim R, Hermansen BE, Hardeland C (2023)
    Ad hoc digital communication and assessment during clinical placements in nursing education; a qualitative research study of students', clinical instructors', and teachers' experiences
    PLoS One, 18 (7), e0287438
    DOI 10.1371/journal.pone.0287438, PubMed 37478099
27. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
    Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 8 (1), 4
    DOI 10.1038/s41541-023-00600-6, PubMed 36697432
28. Wiken TH, Høivik ML, Buer L, Warren DJ, Bolstad N, Moum BA, Anisdahl K, Småstuen MC, Medhus AW (2023)
    Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
    Scand J Gastroenterol, 58 (8), 863-873
    DOI 10.1080/00365521.2023.2176252, PubMed 36799155

Publications 2022

1. de Rijk FEM, van Veldhuisen CL, Besselink MG, van Hooft JE, van Santvoort HC, van Geenen EJM, Hegyi P, Löhr JM, Dominguez-Munoz JE, de Jonge PJF, Bruno MJ, Verdonk RC, Dutch Pancreatitis Study Group (2022)
   Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study
   Pancreatology, 22 (4), 457-465
   DOI 10.1016/j.pan.2022.03.013, PubMed 35346599
2. Erchinger F, Engjom T, Dimcevski G, Drewes AM, Olesen SS, Vujasinovic M, Löhr JM, Nøjgaard C, Novovic S, Laukkarinen J, Parhiala M, Björn L, Waage A, Hauge T, Pukitis A, Ozola-Zalite I, Kalaitzakis E, Okhlobystin A, Barauskas G, Eva Efsen D, Tjora E, Scandinavian Baltic Pancreatic Club (2022)
   Exocrine pancreas insufficiency in chronic pancreatitis - Risk factors and associations with complications. A multicentre study of 1869 patients
   Pancreatology, 22 (3), 374-380
   DOI 10.1016/j.pan.2022.02.003, PubMed 35216905
3. Evensen H, Hjermstad MJ, Cvancarova M, Kristensen V, Larssen L, Skattum J, Hauge T, Sandstad O, Medhus AW (2022)
   Quality of life in patients with achalasia: Associations with Eckardt score and objective treatment outcomes after peroral endoscopic myotomy
   Endosc Int Open, 10 (12), E1570-E1576
   DOI 10.1055/a-1968-7682, PubMed 36531682
4. Haukeland JW, Midgard H, Konopski Z, Sarna VK, Grøtta OJ, Kløw NE (2022)
   [Transjugular intrahepatic portosystemic shunt for portal hypertension]
   Tidsskr Nor Laegeforen, 142 (14)
   DOI 10.4045/tidsskr.21.0911, PubMed 36226423
5. Jelsness-Jørgensen LP, Moum B, Grimstad T, Jahnsen J, Hovde Ø, Frigstad SO, Bernklev T (2022)
   The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients
   Scand J Gastroenterol, 1-7 (in press)
   DOI 10.1080/00365521.2022.2029939, PubMed 35076321
6. Kazmi SSH, Safi N, Berge ST, Kazmi M, Sundhagen JO, Julien K, Thorsby PM, Ånonsen KV, Medhus AW, Hisdal J (2022)
   Plasma α-Glutathione S-Transferase in Patients with Chronic Mesenteric Ischemia and Median Arcuate Ligament Syndrome
   Vasc Health Risk Manag, 18, 567-574
   DOI 10.2147/VHRM.S365625, PubMed 35903288
7. Lindgren S, Hjortswang H, Moum B, Vasko P, H Lund L (2022)
   [Iron deficiency in patients with acute and chronic heart failure - a simple algoritm]
   Lakartidningen, 119
   PubMed 36149233
8. Lorentzen J, Medhus AW, Hofsø D, Svanevik M, Seip B, Hjelmesæth J (2022)
   Letter to the Editor regarding the article «Gerd symptoms after laparoscopic Roux-en-Y gastric bypass: an emerging scenario» by Antonella Santonicola, Luigi Ruggiero, Rossella Palma, Luigi Angrisani and Paola Iovino. International Journal of Obesity (2022) 46:1076-1078
   Int J Obes (Lond), 46 (10), 1936-1937
   DOI 10.1038/s41366-022-01200-5, PubMed 35933446
9. Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
   Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
   J Infect Dis, 225 (4), 661-674
   DOI 10.1093/infdis/jiaa714, PubMed 33216130
10. Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
    Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
    J Acquir Immune Defic Syndr, 89 (1), 77-86
    DOI 10.1097/QAI.0000000000002817, PubMed 34878437
11. Midgard H, Bjørnestad R, Egeland M, Dahl E, Finbråten AK, Kielland KB, Blindheim M, Dalgard O (2022)
    Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs
    Liver Int, 42 (6), 1268-1277
    DOI 10.1111/liv.15266, PubMed 35362660
12. Nordaas IK, Tjora E, Dimcevski G, Haldorsen IS, Olesen SS, Drewes AM, Zviniene K, Barauskas G, Bayram BK, Nørregaard P, Borch A, Nøjgaard C, Jensen AB, Kardasheva SS, Okhlobystin A, Hauge T, Waage A, Frøkjaer JB, Engjom T, Scandinavian Baltic Pancreatic Club (2022)
    Structural imaging findings are related to clinical complications in chronic pancreatitis
    United European Gastroenterol J, 10 (4), 385-395
    DOI 10.1002/ueg2.12228, PubMed 35396813
13. Opheim R, Moum KM, Småstuen MC, Moum B (2022)
    The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway
    Qual Life Res, 32 (3), 691-699
    DOI 10.1007/s11136-022-03254-4, PubMed 36125603
14. Pinto R, Hauge T, Jeanmougin M, Pharo HD, Kresse SH, Honne H, Winge SB, Five MB, Kumar T, Mala T, Hauge T, Johnson E, Lind GE (2022)
    Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus
    Clin Epigenetics, 14 (1), 77
    DOI 10.1186/s13148-022-01287-7, PubMed 35701814
15. Polaris Observatory HCV Collaborators (2022)
    Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
    Lancet Gastroenterol Hepatol, 7 (5), 396-415
    DOI 10.1016/S2468-1253(21)00472-6, PubMed 35180382
16. Safi N, Ånonsen KV, Berge ST, Medhus AW, Sundhagen JO, Hisdal J, Kazmi SSH (2022)
    Early Identification of Chronic Mesenteric Ischemia with Endoscopic Duplex Ultrasound
    Vasc Health Risk Manag, 18, 233-243
    DOI 10.2147/VHRM.S358570, PubMed 35431549
17. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
    Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 7 (1), 174
    DOI 10.1038/s41541-022-00586-7, PubMed 36585405
18. Vesterhus M, Jørgensen KK, Frigstad SO, Haukeland JW, Karlsen TH (2022)
    [We need a new strategy for liver disease]
    Tidsskr Nor Laegeforen, 142 (3)
    DOI 10.4045/tidsskr.21.0892, PubMed 35170917
19. Waage A, Vinge-Holmquist O, Labori KJ, Paulsen V, Aabakken L, Lenz H, Felix Magnus HC, Tholfsen T, Hauge T (2022)
    Tailored surgery in chronic pancreatitis after implementation of a multidisciplinary team assessment; a prospective observational study
    HPB (Oxford), 24 (12), 2157-2166
    DOI 10.1016/j.hpb.2022.09.007, PubMed 36272955
20. Zhao M, Lirhus S, Lördal M, Langholz E, Knudsen T, Voutilainen M, Høivik ML, Moum B, Anisdahl K, Saebø B, Haiko P, Malmgren C, Coskun M, Melberg HO, Burisch J (2022)
    Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway
    Aliment Pharmacol Ther, 56 (6), 989-1006
    DOI 10.1111/apt.17145, PubMed 35902223

Publications 2021

1. Anisdahl K, Svatun Lirhus S, Medhus AW, Moum B, Melberg HO, Høivik ML (2021)
   First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
   Scand J Gastroenterol, 56 (10), 1163-1168
   DOI 10.1080/00365521.2021.1955147, PubMed 34320885
2. Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J (2021)
   Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact
   World J Gastroenterol, 27 (17), 2039-2053
   DOI 10.3748/wjg.v27.i17.2039, PubMed 34007138
3. El-Salhy M, Kristoffersen AB, Valeur J, Casen C, Hatlebakk JG, Gilja OH, Hausken T (2021)
   Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
   Neurogastroenterol Motil, 34 (1), e14200
   DOI 10.1111/nmo.14200, PubMed 34145677
4. Engjom T, Nordaas IK, Tjora E, Dimcevski G, Haldorsen IS, Olesen SS, Drewes AM, Zviniene K, Barauskas G, Riis Jespersen HS, Jensen N, Borch A, Nøjgaard C, Novovic S, Kardasheva SS, Okhlobystin A, Hauge T, Waage A, Frøkjær JB (2021)
   Aetiological risk factors are associated with distinct imaging findings in patients with chronic pancreatitis: A study of 959 cases from the Scandinavian Baltic Pancreatic Club (SBPC) imaging database
   Pancreatology, 21 (4), 688-697
   DOI 10.1016/j.pan.2021.02.023, PubMed 33707113
5. Evensen H, Småstuen MC, Schulz A, Kristensen V, Larssen L, Skattum J, Sandstad O, Hauge T, Medhus AW (2021)
   One year comprehensive prospective follow-up of achalasia patients after peroral endoscopic myotomy
   Ann Med, 53 (1), 2225-2233
   DOI 10.1080/07853890.2021.2005253, PubMed 34806501
6. Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA, INTRO-HCV Study Group (2021)
   Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
   PLoS Med, 18 (6), e1003653
   DOI 10.1371/journal.pmed.1003653, PubMed 34061883
7. Hoff G, Botteri E, Huppertz-Hauss G, Kvamme JM, Holme Ø, Aabakken L, Dahler S, Medhus AW, Blomgren I, Sandvei P, Darre-Næss O, Kjellevold Ø, Seip B (2021)
   The effect of train-the-colonoscopy-trainer course on colonoscopy quality indicators
   Endoscopy, 53 (12), 1229-1234
   DOI 10.1055/a-1352-4583, PubMed 33622001
8. Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø (2021)
   Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
   BMJ Open, 11 (6), e048541
   DOI 10.1136/bmjopen-2020-048541, PubMed 34168032
9. Kristensen VA, Opheim R, Perminow G, Huppertz-Hauss G, Detlie TE, Lund C, Andersen S, Olsen BC, Johansen I, Medhus AW, Vatn S, Brackmann S, Olbjørn C, Rove J, Henriksen M, Løvlund EE, Bengtson MB, Aabrekk TB, Tønnessen T, Vikskjold FB, Yassin H, Frigstad SO, Hasund A, Høie O, Schmidt K et al. (2021)
   Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway
   Scand J Gastroenterol, 56 (8), 899-905
   DOI 10.1080/00365521.2021.1922746, PubMed 34154494
10. Kylänpää L, Koskensalo V, Saarela A, Ejstrud P, Udd M, Lindström O, Rainio M, Tenca A, Halttunen J, Qvigstad G, Arnelo U, Fagerström N, Hauge T, Aabakken L, Grönroos J (2021)
    Transpancreatic biliary sphincterotomy versus double guidewire in difficult biliary cannulation: a randomized controlled trial
    Endoscopy, 53 (10), 1011-1019
    DOI 10.1055/a-1327-2025, PubMed 33440441
11. Lirhus SS, Høivik ML, Moum B, Anisdahl K, Melberg HO (2021)
    Incidence and Prevalence of Inflammatory Bowel Disease in Norway and the Impact of Different Case Definitions: A Nationwide Registry Study
    Clin Epidemiol, 13, 287-294
    DOI 10.2147/CLEP.S303797, PubMed 33935519
12. Lorentzen J, Medhus AW, Hofsø D, Svanevik M, Seip B, Hjelmesæth J (2021)
    Sleeve Gastrectomy Confers Higher Risk of Gastroesophageal Reflux Disease Than Gastric Bypass: A Randomized Controlled Trial From the Oseberg Reflux Working Group
    Gastroenterology, 161 (6), 2044-2046.e4
    DOI 10.1053/j.gastro.2021.08.021, PubMed 34419459
13. Lorvik KB, Meyer-Myklestad MH, Kushekar K, Handeland C, Medhus AW, Lund-Iversen M, Stiksrud B, Kvale D, Dyrhol-Riise AM, Taskén K, Reikvam DH (2021)
    Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4⁺ T Cells in HIV-Infected Immunological Non-Responders
    Front Immunol, 12, 744155
    DOI 10.3389/fimmu.2021.744155, PubMed 34691047
14. Midgard H, Ulstein K, Backe Ø, Foshaug T, Sørli H, Vennesland K, Nilssen D, Dahl EH, Finbråten AK, Wüsthoff L, Dalgard O (2021)
    Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
    Int J Drug Policy, 96, 103165
    DOI 10.1016/j.drugpo.2021.103165, PubMed 33642182
15. Monstad IL, Solberg IC, Cvancarova M, Hovde O, Henriksen M, Huppertz-Hauss G, Gunther E, Moum BA, Stray N, Vatn M, Hoie O, Jahnsen J (2021)
    Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study
    J Crohns Colitis, 15 (6), 969-979
    DOI 10.1093/ecco-jcc/jjaa232, PubMed 33367569
16. Moum KM, Moum B, Opheim R (2021)
    Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic
    Scand J Gastroenterol, 56 (5), 545-551
    DOI 10.1080/00365521.2021.1901308, PubMed 33771086
17. Njølstad T, Young VS, Drolsum A, Dormagen JB, Hofstad B, Schulz A (2021)
    Is there need for routine CT colonography after CT-verified uncomplicated diverticulitis of the sigmoid colon?
    Eur J Radiol Open, 8, 100341
    DOI 10.1016/j.ejro.2021.100341, PubMed 33898653
18. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
19. Sousa P, Ministro P, Armuzzi A, Dignass A, Høivik ML, Barreiro-de Acosta M, Vavricka S, Saad-Hossne R, Kotze PG, Peyrin-Biroulet L, Magro F (2021)
    Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease
    Dig Liver Dis, 53 (12), 1571-1579
    DOI 10.1016/j.dld.2021.05.038, PubMed 34187768
20. Stamnaes J, Stray D, Stensland M, Sarna VK, Nyman TA, Lundin KEA, Sollid LM (2021)
    In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten Challenge
    Adv Sci (Weinh), 8 (4), 2003526
    DOI 10.1002/advs.202003526, PubMed 33643806
21. Tjønnfjord SKV, Tjønnfjord EB, Konopski Z, Tjønnfjord GE (2021)
    Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
    Case Rep Hematol, 2021, 1862446
    DOI 10.1155/2021/1862446, PubMed 34721911
22. Tønnesen CJ, Hjelmesæth J, Hofsø D, Tonstad S, Hertel JK, Heggen E, Johnson LK, Mathisen TE, Kalager M, Wieszczy P, Medhus AW, Løberg M, Aabakken L, Bretthauer M (2021)
    A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial
    Scand J Gastroenterol, 57 (2), 232-238
    DOI 10.1080/00365521.2021.1994641, PubMed 34714203

Publications 2020

1. Berge ST, Safi N, Medhus AW, Sundhagen JO, Hisdal J, Kazmi SSH (2020)
   Perioperative Microcirculatory Changes Detected with Gastroscopy Assisted Laser Doppler Flowmetry and Visible Light Spectroscopy in Patients with Median Arcuate Ligament Syndrome
   Vasc Health Risk Manag, 16, 331-341
   DOI 10.2147/VHRM.S252192, PubMed 32982262
2. Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Måge I, Rud I, Aas AM (2020)
   Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
   Eur J Nutr, 59 (7), 3325-3338
   DOI 10.1007/s00394-020-02282-5, PubMed 32440730
3. Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Måge I, Rud I, Aas AM (2020)
   Correction to: Prebiotic effect of inulin‑type fructans on faecal microbiota and short‑chain fatty acids in type 2 diabetes: a randomised controlled trial
   Eur J Nutr, 59 (7), 3339-3340
   DOI 10.1007/s00394-020-02314-0, PubMed 32632657
4. Bärebring L, Kværner AS, Skotnes M, Henriksen HB, Skjetne AJ, Henriksen C, Ræder H, Paur I, Bøhn SK, Wiedswang G, Smeland S, Blomhoff R (2020)
   Use of bioelectrical impedance analysis to monitor changes in fat-free mass during recovery from colorectal cancer- a validation study
   Clin Nutr ESPEN, 40, 201-207
   DOI 10.1016/j.clnesp.2020.09.021, PubMed 33183537
5. El-Salhy M, Valeur J, Hausken T, Gunnar Hatlebakk J (2020)
   Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
   Neurogastroenterol Motil, 33 (2), e13983
   DOI 10.1111/nmo.13983, PubMed 32945066
6. Fretheim H, Chung BK, Didriksen H, Bækkevold ES, Midtvedt Ø, Brunborg C, Holm K, Valeur J, Tennøe AH, Garen T, Midtvedt T, Trøseid M, Zarè H, Lund MB, Hov JR, Lundin KEA, Molberg Ø, Hoffmann-Vold AM (2020)
   Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
   PLoS One, 15 (5), e0232739
   DOI 10.1371/journal.pone.0232739, PubMed 32437393
7. Hauge T, Franco-Lie I, Løberg EM, Hauge T, Johnson E (2020)
   Outcome after endoscopic treatment for dysplasia and superficial esophageal cancer - a cohort study
   Scand J Gastroenterol, 55 (9), 1132-1138
   DOI 10.1080/00365521.2020.1800813, PubMed 32748653
8. Haukeland JW, Småstuen MC, Pålsdatter PP, Ismail M, Konopski Z, Jørgensen KK, Lannerstedt H, Midgard H (2020)
   Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway
   PLoS One, 15 (3), e0230263
   DOI 10.1371/journal.pone.0230263, PubMed 32163489
9. Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW, Rupp C, Vesterhus M, Jørgensen KK, Rorsman F et al. (2020)
   Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
   Clin Gastroenterol Hepatol, 18 (10), 2295-2304.e2
   DOI 10.1016/j.cgh.2020.02.014, PubMed 32068151
10. Jørgensen KK, Goll GL, Sexton J, Bolstad N, Olsen IC, Asak Ø, Berset IP, Blomgren IM, Dvergsnes K, Florholmen J, Frigstad SO, Henriksen M, Hagfors J, Huppertz-Hauss G, Haavardsholm EA, Klaasen RA, Moum B, Noraberg G, Prestegård U, Rydning JH, Sagatun L, Seeberg KA, Torp R, Vold C, Warren DJ et al. (2020)
    Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
    BioDrugs, 34 (5), 681-694
    DOI 10.1007/s40259-020-00438-7, PubMed 32965617
11. Kazmi SSH, Berge ST, Sahba M, Medhus AW, Sundhagen JO (2020)
    A Short Series of Laparoscopic Mesenteric Bypasses for Chronic Mesenteric Ischemia
    Vasc Health Risk Manag, 16, 87-97
    DOI 10.2147/VHRM.S243264, PubMed 32256075
12. Klepp P, Brackmann S, Cvancarova M, Hoivik ML, Hovde Ø, Henriksen M, Huppertz-Hauss G, Bernklev T, Hoie O, Kempski-Monstad I, Solberg IC, Stray N, Jahnsen J, Vatn MH, Moum B (2020)
    Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
    BMJ Open Gastroenterol, 7 (1), e000361
    DOI 10.1136/bmjgast-2019-000361, PubMed 32337058
13. Kravdal Ø, Magnus P, Moum B, Høivik ML (2020)
    Association of Childbearing With a Short-Term Reduced Risk of Crohn Disease in Mothers
    Am J Epidemiol, 189 (4), 294-304
    DOI 10.1093/aje/kwz285, PubMed 31907543
14. Kristensen VA, Cvancarova M, Høivik ML, Moum B, Vatn MH (2020)
    Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study
    Scand J Gastroenterol, 55 (4), 436-441
    DOI 10.1080/00365521.2020.1745879, PubMed 32252542
15. Kummen M, Thingholm LB, Rühlemann MC, Holm K, Hansen SH, Moitinho-Silva L, Liwinski T, Zenouzi R, Storm-Larsen C, Midttun Ø, McCann A, Ueland PM, Høivik ML, Vesterhus M, Trøseid M, Laudes M, Lieb W, Karlsen TH, Bang C, Schramm C, Franke A, Hov JR (2020)
    Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
    Gastroenterology, 160 (5), 1784-1798.e0
    DOI 10.1053/j.gastro.2020.12.058, PubMed 33387530
16. Lorentzen J, Medhus AW, Hertel JK, Borgeraas H, Karlsen TI, Kolotkin RL, Sandbu R, Sifrim D, Svanevik M, Hofsø D, Seip B, Hjelmesæth J (2020)
    Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study
    Obes Surg, 30 (7), 2667-2675
    DOI 10.1007/s11695-020-04545-w, PubMed 32193740
17. Midgard H, Finbråten AK, Malme KB, Berg-Pedersen RM, Tanum L, Olsen IC, Bjørnestad R, Dalgard O (2020)
    Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs
    Trials, 21 (1), 524
    DOI 10.1186/s13063-020-04434-8, PubMed 32539853
18. Olesen SS, Nøjgaard C, Novovic S, Jensen NM, Nørregaard P, Dahl EE, Waage A, Hauge T, Barauskas G, Parhiala M, Laukkarinen J, Drewes AM (2020)
    Pain and aetiological risk factors determine quality of life in patients with chronic pancreatitis, but a brick in the puzzle is missing
    Pancreatology, 20 (7), 1347-1353
    DOI 10.1016/j.pan.2020.09.004, PubMed 32948428
19. Olesen SS, Poulsen JL, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, Engjom T, Tjora E, Waage A, Hauge T, Haas SL, Vujasinovic M, Barauskas G, Pukitis A, Ozola-Zālīte I, Okhlobystin A, Parhiala M, Laukkarinen J, Drewes AM (2020)
    Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases
    United European Gastroenterol J, 8 (4), 453-461
    DOI 10.1177/2050640620901973, PubMed 32213024
20. Opheim R, Moum B, Grimstad BT, Jahnsen J, Prytz Berset I, Hovde Ø, Huppertz-Hauss G, Bernklev T, Jelsness-Jørgensen LP (2020)
    Self-esteem in patients with inflammatory bowel disease
    Qual Life Res, 29 (7), 1839-1846
    DOI 10.1007/s11136-020-02467-9, PubMed 32144613
21. Ossum AM, Palm Ø, Cvancarova M, Bernklev T, Jahnsen J, Moum B, Høivik ML, IBSEN Study Group (2020)
    The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study)
    Inflamm Bowel Dis, 26 (1), 114-124
    DOI 10.1093/ibd/izz105, PubMed 31127829
22. Safi N, Johannessen HO, Medhus AW, Mala T, Kazmi SSH (2020)
    Laser Doppler Flowmetry and Visible Light Spectroscopy of the Gastric Tube During Minimally Invasive Esophagectomy
    Vasc Health Risk Manag, 16, 497-505
    DOI 10.2147/VHRM.S269138, PubMed 33273819
23. Tjora E, Dimcevski G, Haas SL, Erchinger F, Vujasinovic M, Löhr M, Nøjgaard C, Novovic S, Zalite IO, Pukitis A, Hauge T, Waage A, Roug S, Kalaitzakis E, Lindkvist B, Olesen SS, Engjom T, Scandinavian Baltic Pancreatic Club (2020)
    Patient reported exposure to smoking and alcohol abuse are associated with pain and other complications in patients with chronic pancreatitis
    Pancreatology, 20 (5), 844-851
    DOI 10.1016/j.pan.2020.05.001, PubMed 32507681
24. Vesterhus M, Nielsen MJ, Hov JR, Saffioti F, Manon-Jensen T, Leeming DJ, Moum B, Boberg KM, Pinzani M, Karlsen TH, Karsdal MA, Thorburn D (2020)
    Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease
    JHEP Rep, 3 (1), 100178
    DOI 10.1016/j.jhepr.2020.100178, PubMed 33225252

Publications 2019

1. Berge ST, Safi N, Medhus AW, Ånonsen K, Sundhagen JO, Hisdal J, Kazmi SSH (2019)
   Gastroscopy assisted laser Doppler flowmetry and visible light spectroscopy in patients with chronic mesenteric ischemia
   Scand J Clin Lab Invest, 79 (7), 541-549
   DOI 10.1080/00365513.2019.1672084, PubMed 31560225
2. Bjørkhaug ST, Neupane SP, Bramness JG, Aanes H, Skar V, Medhus AW, Valeur J (2019)
   Plasma cytokine levels in patients with chronic alcohol overconsumption: Relations to gut microbiota markers and clinical correlates
   Alcohol, 85, 35-40
   DOI 10.1016/j.alcohol.2019.10.002, PubMed 31610228
3. Bjørkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW, Valeur J (2019)
   Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption
   Gut Microbes, 10 (6), 663-675
   DOI 10.1080/19490976.2019.1580097, PubMed 30894059
4. Buer LCT, Moum BA, Cvancarova M, Warren DJ, Bolstad N, Medhus AW, Høivik ML (2019)
   Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort
   Scand J Gastroenterol, 54 (1), 41-48
   DOI 10.1080/00365521.2018.1548646, PubMed 30650312
5. Dale HF, Jensen C, Hausken T, Valeur J, Hoff DAL, Lied GA (2019)
   Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome
   Nutrients, 11 (7)
   DOI 10.3390/nu11071635, PubMed 31319590
6. Detlie TE, Lindstrøm JC, Jahnsen ME, Finnes E, Zoller H, Moum B, Jahnsen J (2019)
   Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside
   Aliment Pharmacol Ther, 50 (4), 397-406
   DOI 10.1111/apt.15386, PubMed 31264261
7. Dominguez-Munoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, Löhr JM, HaPanEU/UEG Working Group (2019)
   Corrigendum to "Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis" [Pancreatology 18(8) (2018) 847-854]
   Pancreatology, 20 (1), 148
   DOI 10.1016/j.pan.2019.10.005, PubMed 31757740
8. Evensen H, Kristensen V, Larssen L, Sandstad O, Hauge T, Medhus AW (2019)
   Outcome of peroral endoscopic myotomy (POEM) in treatment-naive patients. A systematic review
   Scand J Gastroenterol, 54 (1), 1-7
   DOI 10.1080/00365521.2018.1549271, PubMed 30650313
9. Evensen H, Medhus AW (2019)
   Response to letter to the editor: 'Outcome of peroral endoscopic myotomy (POEM) in treatment-naive patients. A systematic review'
   Scand J Gastroenterol, 54 (4), 520
   DOI 10.1080/00365521.2019.1599416, PubMed 30978123
10. Fadnes LT, Aas CF, Vold JH, Ohldieck C, Leiva RA, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA, INTRO-HCV Study Group (2019)
    Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
    BMC Infect Dis, 19 (1), 943
    DOI 10.1186/s12879-019-4598-7, PubMed 31703669
11. Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Bernklev T, Moum B, Jelsness-Jørgensen LP (2019)
    Pain Severity and Vitamin D Deficiency in IBD Patients
    Nutrients, 12 (1)
    DOI 10.3390/nu12010026, PubMed 31877637
12. Gidoni M, Snir O, Peres A, Polak P, Lindeman I, Mikocziova I, Sarna VK, Lundin KEA, Clouser C, Vigneault F, Collins AM, Sollid LM, Yaari G (2019)
    Mosaic deletion patterns of the human antibody heavy chain gene locus shown by Bayesian haplotyping
    Nat Commun, 10 (1), 628
    DOI 10.1038/s41467-019-08489-3, PubMed 30733445
13. Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G et al. (2019)
    Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
    J Intern Med, 285 (6), 653-669
    DOI 10.1111/joim.12880, PubMed 30762274
14. Hajarizadeh B, Cunningham EB, Valerio H, Martinello M, Law M, Janjua NZ, Midgard H, Dalgard O, Dillon J, Hickman M, Bruneau J, Dore GJ, Grebely J (2019)
    Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis
    J Hepatol, 72 (4), 643-657
    DOI 10.1016/j.jhep.2019.11.012, PubMed 31785345
15. Haraldsson E, Kylänpää L, Grönroos J, Saarela A, Toth E, Qvigstad G, Hult M, Lindström O, Laine S, Karjula H, Hauge T, Sadik R, Arnelo U (2019)
    Macroscopic appearance of the major duodenal papilla influences bile duct cannulation: a prospective multicenter study by the Scandinavian Association for Digestive Endoscopy Study Group for ERCP
    Gastrointest Endosc, 90 (6), 957-963
    DOI 10.1016/j.gie.2019.07.014, PubMed 31326385
16. Hauge T, Kleven OC, Johnson E, Hofstad B, Johannessen HO (2019)
    Outcome after iatrogenic esophageal perforation
    Scand J Gastroenterol, 54 (2), 140-144
    DOI 10.1080/00365521.2019.1575464, PubMed 30857441
17. Juul FE, Valeur J (2019)
    Kind bacteria do not exist
    Tidsskr. Nor. Laegeforen., 139 (6), 504-505
18. Juul FE, Valeur J (2019)
    Intestinal flora treatment
    Tidsskr. Nor. Laegeforen., 139 (9), 859
19. Juul FE, Valeur J (2019)
    Fecal transplantation and microbiome Reply
    Tidsskr. Nor. Laegeforen., 139 (11), 1020
20. Kristensen VA, Valeur J, Brackmann S, Jahnsen J, Brunborg C, Tveito K (2019)
    Attention deficit and hyperactivity disorder symptoms respond to gluten-free diet in patients with coeliac disease
    Scand J Gastroenterol, 54 (5), 571-576
    DOI 10.1080/00365521.2019.1608467, PubMed 31050907
21. Olesen SS, Lisitskaya MV, Drewes AM, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, Engjom T, Erchinger F, Waage A, Hauge T, Haas SL, Vujasinovic M, Lindkvist B, Zviniene K, Pukitis A, Ozola-Zālīte I, Okhlobystin A, Parhiala M, Laukkarinen J, Frøkjær JB, Scandinavian Baltic Pancreatic Club (2019)
    Pancreatic calcifications associate with diverse aetiological risk factors in patients with chronic pancreatitis: A multicentre study of 1500 cases
    Pancreatology, 19 (7), 922-928
    DOI 10.1016/j.pan.2019.08.009, PubMed 31462382
22. Olesen SS, Nøjgaard C, Poulsen JL, Haas SL, Vujasinovic M, Löhr M, Lindkvist B, Bexander L, Gulbinas A, Kalaitzakis E, Ebrahim M, Erchinger F, Engjom T, Roug S, Novovic S, Hauge T, Waage A, Laukkarinen J, Parhiala M, Pukitis A, Ozola-Zālīte I, Drewes AM, Scandinavian Baltic Pancreatic Club (2019)
    Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk Factors
    Am J Gastroenterol, 114 (4), 656-664
    DOI 10.14309/ajg.0000000000000147, PubMed 30741740
23. Safreed-Harmon K, Blach S, Aleman S, Bollerup S, Cooke G, Dalgard O, Dillon JF, Dore GJ, Duberg AS, Grebely J, Boe Kielland K, Midgard H, Porter K, Razavi H, Tyndall M, Weis N, Lazarus JV (2019)
    The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination
    Clin Infect Dis, 69 (12), 2218-2227
    DOI 10.1093/cid/ciz714, PubMed 31352481
24. Torres J, Ellul P, Langhorst J, Mikocka-Walus A, Barreiro-de Acosta M, Basnayake C, Ding NJS, Gilardi D, Katsanos K, Moser G, Opheim R, Palmela C, Pellino G, Van der Marel S, Vavricka SR (2019)
    European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease
    J Crohns Colitis, 13 (6), 673-685e
    DOI 10.1093/ecco-jcc/jjz051, PubMed 30820529
25. Øvrehus ALH, Midgard H (2019)
    How can we achieve WHO's elimination target for hepatitis C incidence?
    Lancet Gastroenterol Hepatol, 4 (6), 415-417
    DOI 10.1016/S2468-1253(19)30120-7, PubMed 30981687
26. Ånonsen K, Sahakyan MA, Kleive D, Waage A, Verbeke C, Hauge T, Buanes T, Edwin B, Labori KJ (2019)
    Trends in management and outcome of cystic pancreatic lesions - analysis of 322 cases undergoing surgical resection
    Scand J Gastroenterol, 54 (8), 1051-1057
    DOI 10.1080/00365521.2019.1642379, PubMed 31322457

Publications 2018

1. Buer LCT, Høivik ML, Warren DJ, Medhus AW, Moum BA (2018)
   Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series
   Inflamm Bowel Dis, 24 (5), 997-1004
   DOI 10.1093/ibd/izx110, PubMed 29668901
2. Day E, Hellard M, Treloar C, Bruneau J, Martin NK, Øvrehus A, Dalgard O, Lloyd A, Dillon J, Hickman M, Byrne J, Litwin A, Maticic M, Bruggmann P, Midgard H, Norton B, Trooskin S, Lazarus JV, Grebely J, International Network on Hepatitis in Substance Users (INHSU) (2018)
   Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
   Liver Int, 39 (1), 20-30
   DOI 10.1111/liv.13949, PubMed 30157316
3. Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
   Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
   Liver Int, 39 (2), 371-381
   DOI 10.1111/liv.13979, PubMed 30269440
4. Dominguez-Munoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, Löhr JM, HaPanEU/UEG Working Group (2018)
   Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
   Pancreatology, 18 (8), 847-854
   DOI 10.1016/j.pan.2018.09.016, PubMed 30344091
5. Engebretsen KV, Blom-Høgestøl IK, Hewitt S, Risstad H, Moum B, Kristinsson JA, Mala T (2018)
   Anemia following Roux-en-Y gastric bypass for morbid obesity; a 5-year follow-up study
   Scand J Gastroenterol, 53 (8), 917-922
   DOI 10.1080/00365521.2018.1489892, PubMed 30231804
6. European Study Group on Cystic Tumours of the Pancreas (2018)
   European evidence-based guidelines on pancreatic cystic neoplasms
   Gut, 67 (5), 789-804
   DOI 10.1136/gutjnl-2018-316027, PubMed 29574408
7. Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Bernklev T, Moum B, Jelsness-Jørgensen LP (2018)
   Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients
   World J Gastroenterol, 24 (29), 3293-3301
   DOI 10.3748/wjg.v24.i29.3293, PubMed 30090009
8. Hauge T, Kleven OC, Johnson E, Hofstad B, Johannessen HO (2018)
   Outcome after stenting and débridement for spontaneous esophageal rupture
   Scand J Gastroenterol, 53 (4), 398-402
   DOI 10.1080/00365521.2018.1448886, PubMed 29523026
9. Hauge T, Kleven OC, Johnson E, Hofstad B, Johannessen HO (2018)
   Outcome after accidental food bolus-induced esophageal perforation
   Scand J Gastroenterol, 53 (8), 905-909
   DOI 10.1080/00365521.2018.1495760, PubMed 30231806
10. Henriksen M, Høivik ML, Jelsness-Jørgensen LP, Moum B, IBSEN Study Group (2018)
    Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study]
    J Crohns Colitis, 12 (4), 389-393
    DOI 10.1093/ecco-jcc/jjx152, PubMed 29186372
11. Hicks SA, Riegler M, Pogorelov K, Anonsen KV, de Lange T, Johansen D, Jeppsson M, Randel KR, Eskeland S, Halvorsen P (2018)
    Dissecting Deep Neural Networks for Better Medical Image Classification and Classification Understanding
    COMP MED SY, 363-368
    DOI 10.1109/CBMS.2018.00070
12. Holme Ø, Pedersen IB, Medhus AW, Aabakken L, Glomsaker T, Kvamme JM, Løberg M, Bretthauer M, Seip B, Kjellevold Ø, Jørgensen A, Furholm S, Hoff G, de Lange T (2018)
    Endoscopy assistants influence the quality of colonoscopy
    Endoscopy, 50 (9), 871-877
    DOI 10.1055/s-0044-101706, PubMed 29444529
13. Høivik ML, Buer LCT, Cvancarova M, Warren DJ, Bolstad N, Moum BA, Medhus AW (2018)
    Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population
    Scand J Gastroenterol, 53 (6), 692-699
    DOI 10.1080/00365521.2018.1463391, PubMed 29852793
14. Klepp P, Kisiel JB, Småstuen MC, Røseth A, Andersen SN, Vatn MH, Ahlquist DA, Moum BA, Brackmann S (2018)
    Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study
    Scand J Gastroenterol, 53 (3), 273-278
    DOI 10.1080/00365521.2018.1424935, PubMed 29313389
15. Lirhus SS, Høivik ML, Moum B, Melberg HO (2018)
    Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study
    Scand J Gastroenterol, 53 (8), 952-957
    DOI 10.1080/00365521.2018.1495258, PubMed 30205699
16. Midgard H, Kielland KB, Dalgard O (2018)
    Elimination of Hepatitis C is possible
    Tidsskr. Nor. Laegeforen., 138 (7), 630-633
17. Ossum AM, Palm Ø, Cvancarova M, Solberg IC, Vatn M, Moum B, Høivik ML, IBSEN study group (2018)
    Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study
    Scand J Gastroenterol, 53 (10-11), 1250-1256
    DOI 10.1080/00365521.2018.1518482, PubMed 30353756
18. Ossum AM, Palm Ø, Lunder AK, Cvancarova M, Banitalebi H, Negård A, Høie O, Henriksen M, Moum BA, Høivik ML, IBSEN Study Group (2018)
    Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study
    J Crohns Colitis, 12 (1), 96-104
    DOI 10.1093/ecco-jcc/jjx126, PubMed 28961700
19. Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C et al. (2018)
    Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries
    Gastroenterology, 155 (4), 1079-1089.e3
    DOI 10.1053/j.gastro.2018.06.043, PubMed 29958857

Publications 2017

1. Aghdassi AA, Schneider A, Kahl M, Schütte K, Kuliaviene I, Salacone P, Lutz J, Tukiainen E, Simon P, Schauer B, Uomo G, Hauge T, Ceyhan GO (2017)
   Analysis of lifestyle factors in patients with concomitant chronic pancreatitis and liver cirrhosis
   Pancreatology, 17 (5), 698-705
   DOI 10.1016/j.pan.2017.07.194, PubMed 28784575
2. Bjørkhaug ST, Skar V, Medhus AW, Tollisen A, Bramness JG, Valeur J (2017)
   Chronic alcohol overconsumption may alter gut microbial metabolism: a retrospective study of 719 ¹³C-D-xylose breath test results
   Microb Ecol Health Dis, 28 (1), 1301725
   DOI 10.1080/16512235.2017.1301725, PubMed 28572752
3. Bjøro B, Dalgard O, Midgard H, Verbaan H, Småstuen MC, Rustøen T (2017)
   Increased hope following successful treatment for hepatitis C infection
   J Adv Nurs, 74 (3), 724-733
   DOI 10.1111/jan.13487, PubMed 29082540
4. Buer L, Høivik ML, Medhus AW, Moum B (2017)
   Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?
   Dig Dis, 35 (1-2), 74-82
   DOI 10.1159/000449087, PubMed 28147370
5. Buer LC, Moum BA, Cvancarova M, Warren DJ, Medhus AW, Høivik ML (2017)
   Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study
   J Crohns Colitis, 11 (3), 297-304
   DOI 10.1093/ecco-jcc/jjw166, PubMed 27660339
6. Burisch J, Vegh Z, Katsanos KH, Christodoulou DK, Lazar D, Goldis A, O'Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olse J, Rubek Nielsen K, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O et al. (2017)
   Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study
   J Crohns Colitis, 11 (10), 1213-1222
   DOI 10.1093/ecco-jcc/jjx077, PubMed 28575481
7. Grebely J, Bruneau J, Lazarus JV, Dalgard O, Bruggmann P, Treloar C, Hickman M, Hellard M, Roberts T, Crooks L, Midgard H, Larney S, Degenhardt L, Alho H, Byrne J, Dillon JF, Feld JJ, Foster G, Goldberg D, Lloyd AR, Reimer J, Robaeys G, Torrens M, Wright N, Maremmani I et al. (2017)
   Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
   Int J Drug Policy, 47, 51-60
   DOI 10.1016/j.drugpo.2017.05.019, PubMed 28683982
8. Grebely J, Dalgard O, Cunningham EB, Hajarizadeh B, Foster GR, Bruggmann P, Conway B, Backmund M, Robaeys G, Swan T, Amin J, Marks PS, Quiene S, Applegate TL, Weltman M, Shaw D, Dunlop A, Hellard M, Bruneau J, Midgard H, Bourgeois S, Staehelin C, Dore GJ, ACTIVATE Study Group (2017)
   Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
   Int J Drug Policy, 47, 177-186
   DOI 10.1016/j.drugpo.2017.05.020, PubMed 28624134
9. Hauge T, Ånonsen KV, Buanes T (2017)
   Management of Pancreatic Cysts (PC)- Based on Cumulative Knowledge
   EC Gastroenterology and Digestive System, 02 (2017), s. 437-39
   PublikaID 402
10. Hellum M, Franco-Lie I, Øvstebø R, Hauge T, Henriksson CE (2017)
    The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls
    PLoS One, 12 (9), e0184579
    DOI 10.1371/journal.pone.0184579, PubMed 28910348
11. Henriksen HB, Ræder H, Bøhn SK, Paur I, Kværner AS, Billington SÅ, Eriksen MT, Wiedsvang G, Erlund I, Færden A, Veierød MB, Zucknick M, Smeland S, Blomhoff R (2017)
    The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial
    BMC Cancer, 17 (1), 83
    DOI 10.1186/s12885-017-3072-4, PubMed 28137255
12. Hovde Ø, Høivik ML, Henriksen M, Solberg IC, Småstuen MC, Moum BA (2017)
    Corrigendum: Malignancies in Patients with Inflammatory Bowel Disease (IBD): Results from 20 Years of Follow-up in the IBSEN (Inflammatory Bowel South-Eastern Norway) Study
    J Crohns Colitis, 11 (12), 1511
    DOI 10.1093/ecco-jcc/jjw218, PubMed 28039308
13. Hovde Ø, Høivik ML, Henriksen M, Solberg IC, Småstuen MC, Moum BA (2017)
    Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study
    J Crohns Colitis, 11 (5), 571-577
    DOI 10.1093/ecco-jcc/jjw193, PubMed 28453756
14. Jahnsen FL, Bækkevold ES, Hov JR, Landsverk OJ (2017)
    Do Long-Lived Plasma Cells Maintain a Healthy Microbiota in the Gut?
    Trends Immunol, 39 (3), 196-208
    DOI 10.1016/j.it.2017.10.006, PubMed 29162322
15. Kristensen V, Røseth A, Ahmad T, Skar V, Moum B (2017)
    Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
    Gastroenterol Res Pract, 2017, 2098293
    DOI 10.1155/2017/2098293, PubMed 29225617
16. Lerdal A, Opheim R, Gay CL, Moum B, Fagermoen MS, Kottorp A (2017)
    Psychometric limitations of the 13-item Sense of Coherence Scale assessed by Rasch analysis
    BMC Psychol, 5 (1), 18
    DOI 10.1186/s40359-017-0187-y, PubMed 28595651
17. Löhr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias-Garcia J, Keller J, Boermeester M, Werner J, Dumonceau JM, Fockens P, Drewes A, Ceyhan G, Lindkvist B, Drenth J, Ewald N, Hardt P, de Madaria E, Witt H, Schneider A, Manfredi R et al. (2017)
    United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
    United European Gastroenterol J, 5 (2), 153-199
    DOI 10.1177/2050640616684695, PubMed 28344786
18. Midgard H, Hajarizadeh B, Cunningham EB, Conway B, Backmund M, Bruggmann P, Bruneau J, Bourgeois S, Dunlop A, Foster GR, Hellard M, Robaeys G, Thurnheer MC, Weltman M, Amin J, Marks PS, Quiene S, Dore GJ, Dalgard O, Grebely J, ACTIVATE Study Group (2017)
    Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study
    Int J Drug Policy, 47, 230-238
    DOI 10.1016/j.drugpo.2017.05.040, PubMed 28633998
19. Tronstad RR, Kummen M, Holm K, von Volkmann HL, Anmarkrud JA, Høivik ML, Moum B, Gilja OH, Hausken T, Baines J, Karlsen TH, Fiskerstrand T, Hov JR (2017)
    Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease
    Inflamm Bowel Dis, 23 (10), 1752-1761
    DOI 10.1097/MIB.0000000000001264, PubMed 28902124
20. Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F (2017)
    Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
    J Hepatol, 66 (6), 1214-1222
    DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472
21. Ånonsen KV, Fagerland MW, Edwin B, Labori KJ, Kure EH, Hauge T, Buanes T (2017)
    Cyst fluid CEA concentration discriminates between benign and premalignant/malignant pancreatic cystic lesions. A prospective cohort study. Short title: Diagnostic yield of pancreatic cyst fluid CEA analysis
    EC Gastroenterology and Digestive System, 02, S. 426-436
    PublikaID 401

Publications 2016

1. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
   Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
   Cancer Med, 5 (8), 1840-9
   DOI 10.1002/cam4.766, PubMed 27273130
2. Follin-Arbelet B, Moum B (2016)
   Fluoride: a risk factor for inflammatory bowel disease?
   Scand J Gastroenterol, 51 (9), 1019-24
   DOI 10.1080/00365521.2016.1177855, PubMed 27199224
3. Frigstad SO, Høivik M, Jahnsen J, Dahl SR, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Torp R, Bernklev T, Moum B, Jelsness-Jørgensen LP (2016)
   Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population
   Scand J Gastroenterol, 52 (1), 100-106
   DOI 10.1080/00365521.2016.1233577, PubMed 27603182
4. Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH (2016)
   Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
   Liver Int, 37 (3), 458-465
   DOI 10.1111/liv.13238, PubMed 27558072
5. Hovde Ø, Småstuen MC, Høivik ML, Bernklev T, Huppertz-Hauss G, Høie O, Jahnsen J, Stray N, Henriksen M, Solberg IC, Moum BA (2016)
   Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study
   Inflamm Bowel Dis, 22 (1), 141-5
   DOI 10.1097/MIB.0000000000000582, PubMed 26355464
6. Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, Opheim R, Henriksen M, Høie O, Hovde Ø, Kempski-Monstad I, Solberg IC, Jahnsen J, Hoff G, Moum B, Bernklev T (2016)
   Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study
   Scand J Gastroenterol, 52 (3), 351-358
   DOI 10.1080/00365521.2016.1256425, PubMed 27852169
7. Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, Henriksen M, Høie O, Jahnsen J, Hoff G, Moum B, Bernklev T (2016)
   Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study
   Inflamm Bowel Dis, 22 (7), 1679-87
   DOI 10.1097/MIB.0000000000000806, PubMed 27206016
8. Huppertz-Hauss G, Aas E, Lie Høivik M, Langholz E, Odes S, Småstuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T (2016)
   Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis
   Gastroenterol Res Pract, 2016, 5023973
   DOI 10.1155/2016/5023973, PubMed 27630711
9. Jelsness-Jørgensen LP, Frigstad SO, Moum B, Grimstad T, Opheim R, Jahnsen J, Bernklev T (2016)
   Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue
   United European Gastroenterol J, 5 (5), 687-693
   DOI 10.1177/2050640616674654, PubMed 28815032
10. Jelsness-Jørgensen LP, Moum B, Grimstad T, Jahnsen J, Opheim R, Prytz Berset I, Hovde Ø, Torp R, Frigstad SO, Huppertz-Hauss G, Bernklev T (2016)
    Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease
    Can J Gastroenterol Hepatol, 2016, 5624261
    DOI 10.1155/2016/5624261, PubMed 27446848
11. Jørgensen SF, Trøseid M, Kummen M, Anmarkrud JA, Michelsen AE, Osnes LT, Holm K, Høivik ML, Rashidi A, Dahl CP, Vesterhus M, Halvorsen B, Mollnes TE, Berge RK, Moum B, Lundin KE, Fevang B, Ueland T, Karlsen TH, Aukrust P, Hov JR (2016)
    Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
    Mucosal Immunol, 9 (6), 1455-1465
    DOI 10.1038/mi.2016.18, PubMed 26982597
12. Knatten CK, Fjeld JG, Medhus AW, Pripp AH, Fyhn TJ, Aabakken L, Kjosbakken H, Edwin B, Emblem R, Bjørnland K (2016)
    Preoperative liquid gastric emptying rate does not predict outcome after fundoplication
    J Pediatr Surg, 52 (4), 540-543
    DOI 10.1016/j.jpedsurg.2016.09.068, PubMed 28277299
13. Kristensen V, Lauritzen T, Jelsness-Jørgensen LP, Frigstad SO, Corwin C, Moum B (2016)
    Patient-performed extraction of faecal calprotectin
    Clin Chem Lab Med, 54 (8), 1357-63
    DOI 10.1515/cclm-2015-1037, PubMed 26812797
14. Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR (2016)
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
    Gut, 66 (4), 611-619
    DOI 10.1136/gutjnl-2015-310500, PubMed 26887816
15. Kummen M, Vesterhus M, Trøseid M, Moum B, Svardal A, Boberg KM, Aukrust P, Karlsen TH, Berge RK, Hov JR (2016)
    Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
    United European Gastroenterol J, 5 (4), 532-541
    DOI 10.1177/2050640616663453, PubMed 28588885
16. Lunder AK, Hov JR, Borthne A, Gleditsch J, Johannesen G, Tveit K, Viktil E, Henriksen M, Hovde Ø, Huppertz-Hauss G, Høie O, Høivik ML, Monstad I, Solberg IC, Jahnsen J, Karlsen TH, Moum B, Vatn M, Negård A (2016)
    Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
    Gastroenterology, 151 (4), 660-669.e4
    DOI 10.1053/j.gastro.2016.06.021, PubMed 27342213
17. Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
    Hepatitis C reinfection after sustained virological response
    J Hepatol, 64 (5), 1020-1026
    DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289
18. Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O (2016)
    Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study
    PLoS One, 11 (11), e0166451
    DOI 10.1371/journal.pone.0166451, PubMed 27846264
19. Midgard H, Weir A, Palmateer N, Lo Re V, Pineda JA, Macías J, Dalgard O (2016)
    HCV epidemiology in high-risk groups and the risk of reinfection
    J Hepatol, 65 (1 Suppl), S33-S45
    DOI 10.1016/j.jhep.2016.07.012, PubMed 27641987
20. Opheim R, Lie Høivik M, Bernklev T, Jelsness-Jørgensen LP, Moum B (2016)
    The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life
    Gastroenterol Res Pract, 2016, 6453657
    DOI 10.1155/2016/6453657, PubMed 28003821
21. Siegel CA, Whitman CB, Spiegel BMR, Feagan B, Sands B, Loftus EV, Panaccione R, D'Haens G, Bernstein CN, Gearry R, Ng SC, Mantzaris GJ, Sartor B, Silverberg MS, Riddell R, Koutroubakis IE, O'Morain C, Lakatos PL, McGovern DPB, Halfvarson J, Reinisch W, Rogler G, Kruis W, Tysk C, Schreiber S et al. (2016)
    Development of an index to define overall disease severity in IBD
    Gut, 67 (2), 244-254
    DOI 10.1136/gutjnl-2016-312648, PubMed 27780886
22. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
    Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study
    PLoS One, 11 (3), e0150191
    DOI 10.1371/journal.pone.0150191, PubMed 26933886
23. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
    Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSanTM, on Symptoms, Fatigue and Quality of Life in Patients with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study
    PLoS One, 11 (7), e0159288
    DOI 10.1371/journal.pone.0159288, PubMed 27415795
24. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
    Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan^™ , in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single-Blinded Placebo-Controlled Study
    Scand J Immunol, 84 (6), 323-331
    DOI 10.1111/sji.12476, PubMed 27588816

Publications 2015

1. Anonsen KV, Buanes T, Rosok BI, Hauge T, Edwin B (2015)
   Outcome of Laparoscopic Surgery in Patients with Cystic Lesions in the Distal Pancreas
   J. Pancreas, 16 (3), 266-270
2. Hauge T, Hauge PW, Warloe T, Drolsum A, Johansen C, Viktil E, Aabakken L, Buanes T, Konopski Z (2015)
   Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study
   Photodiagnosis Photodyn Ther, 13, 330-333
   DOI 10.1016/j.pdpdt.2015.09.004, PubMed 26415549
3. Huppertz-Hauss G, Høivik ML, Langholz E, Odes S, Småstuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T (2015)
   Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis
   Inflamm Bowel Dis, 21 (2), 337-44
   DOI 10.1097/MIB.0000000000000272, PubMed 25569735
4. Jelsness-Jørgensen LP, Bernklev T, Hovde Ø, Prytz Berset I, Huppertz-Hauss G, Moum B, Lie Høivik M (2015)
   Patients' perceptions of quality of care and follow-up in inflammatory bowel disease
   Scand J Gastroenterol, 51 (4), 434-41
   DOI 10.3109/00365521.2015.1102319, PubMed 26635189
5. Kristensen V, Klepp P, Cvancarova M, Røseth A, Skar V, Moum B (2015)
   Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin
   J Crohns Colitis, 9 (2), 164-9
   DOI 10.1093/ecco-jcc/jju015, PubMed 25518057
6. Kristensen V, Lauritzen T, Jelsness-JØrgensen LP, Moum B (2015)
   Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods
   Scand J Clin Lab Invest, 75 (5), 355-61
   DOI 10.3109/00365513.2015.1030765, PubMed 25856663
7. Kristensen V, Malmstrøm GH, Skar V, Røseth A, Moum B (2015)
   Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure
   Scand J Gastroenterol, 51 (5), 548-55
   DOI 10.3109/00365521.2015.1117650, PubMed 26634305
8. Kristensen V, Moum B (2015)
   Correspondence: fecal calprotectin and cut-off levels in inflammatory bowel disease
   Scand J Gastroenterol, 50 (9), 1183-4
   DOI 10.3109/00365521.2015.1025830, PubMed 25772406
9. Løvik A, Skodje G, Bratlie J, Brottveit M, Lundin KE (2015)
   Diet adherence and gluten exposure in coeliac disease and self-reported non-coeliac gluten sensitivity
   Clin Nutr, 36 (1), 275-280
   DOI 10.1016/j.clnu.2015.11.017, PubMed 26714791
10. Moum B (2015)
    Challenges in the care of IBD in patients of all ages
    Tidsskr. Nor. Laegeforen., 135 (2), 157
    DOI 10.4045/tidsskr.14.1267
11. Otterdal K, Haukeland JW, Yndestad A, Dahl TB, Holm S, Segers FM, Gladhaug IP, Konopski Z, Damås JK, Halvorsen B, Aukrust P (2015)
    Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation
    Clin Transl Gastroenterol, 6 (7), e95
    DOI 10.1038/ctg.2015.23, PubMed 26133108
12. Solberg IC, Høivik ML, Cvancarova M, Moum B, IBSEN Study Group (2015)
    Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study)
    Scand J Gastroenterol, 50 (12), 1456-62
    DOI 10.3109/00365521.2015.1064991, PubMed 26139389
13. Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygård S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Parés A, Ponsioen CY, Pinzani M, Färkkilä M, Moum B, Ueland T, Røsjø H, Rosenberg W, Boberg KM, Karlsen TH (2015)
    Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
    Hepatology, 62 (1), 188-97
    DOI 10.1002/hep.27825, PubMed 25833813

Publications 2014

1. Andenæs R, Bentsen SB, Hvinden K, Fagermoen MS, Lerdal A (2014)
   The relationships of self-efficacy, physical activity, and paid work to health-related quality of life among patients with chronic obstructive pulmonary disease (COPD)
   J Multidiscip Healthc, 7, 239-47
   DOI 10.2147/JMDH.S62476, PubMed 24944515
2. Beisner J, Teltschik Z, Ostaff MJ, Tiemessen MM, Staal FJ, Wang G, Gersemann M, Perminow G, Vatn MH, Schwab M, Stange EF, Wehkamp J (2014)
   TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease
   Am J Physiol Gastrointest Liver Physiol, 307 (5), G487-98
   DOI 10.1152/ajpgi.00347.2013, PubMed 24994854
3. Christophersen A, Ráki M, Bergseng E, Lundin KE, Jahnsen J, Sollid LM, Qiao SW (2014)
   Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge
   United European Gastroenterol J, 2 (4), 268-78
   DOI 10.1177/2050640614540154, PubMed 25083284
4. Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M, International PSC Study Group (IPSCSG) (2014)
   Characterization of animal models for primary sclerosing cholangitis (PSC)
   J Hepatol, 60 (6), 1290-303
   DOI 10.1016/j.jhep.2014.02.006, PubMed 24560657
5. Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, Bergamaschi G, Koutroubakis I, Lindgren S, Morena Fde L, Moum B, Vavricka SR, Schröder O, Herrmann E, Blumenstein I (2014)
   Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis
   Inflamm Bowel Dis, 20 (5), 936-45
   DOI 10.1097/01.MIB.0000442728.74340.fd, PubMed 24572205
6. Gomollón F, Chowers Y, Danese S, Dignass A, Haagen Nielsen O, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H, Reinisch W (2014)
   Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines
   Aliment Pharmacol Ther, 39 (7), 743-4
   DOI 10.1111/apt.12648, PubMed 24588280
7. Halttunen J, Meisner S, Aabakken L, Arnelo U, Grönroos J, Hauge T, Kleveland PM, Nordblad Schmidt P, Saarela A, Swahn F, Toth E, Mustonen H, Löhr JM (2014)
   Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs
   Scand J Gastroenterol, 49 (6), 752-8
   DOI 10.3109/00365521.2014.894120, PubMed 24628493
8. Hauge T, Johnson E, Sandstad O, Johannessen HO, Trondsen E (2014)
   Surgical treatment of epiphrenic oesophageal diverticulum
   Tidsskr Nor Laegeforen, 134 (10), 1047-50
   DOI 10.4045/tidsskr.13.1336, PubMed 24865729
9. Isene R, Bernklev T, Høie O, Langholz E, Tsianos E, Stockbrügger R, Odes S, Småstuen M, Moum B, EC-IBD Study Group (2014)
   Thromboembolism in inflammatory bowel disease: results from a prospective, population-based European inception cohort
   Scand J Gastroenterol, 49 (7), 820-5
   DOI 10.3109/00365521.2014.910545, PubMed 24754745
10. Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B, EC-IBD Study Group (2014)
    Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort
    Scand J Gastroenterol, 50 (3), 300-5
    DOI 10.3109/00365521.2014.991752, PubMed 25535653
11. Iversen PO, Ha L, Blomhoff R, Hauge T, Veierød MB (2014)
    Baseline oxidative defense and survival after 5-7 years among elderly stroke patients at nutritional risk: Follow-up of a randomized, nutritional intervention trial
    Clin Nutr, 34 (4), 775-8
    DOI 10.1016/j.clnu.2014.07.002, PubMed 25108573
12. Jelsness-Jørgensen LP, Bernklev T, Moum B (2014)
    Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain
    Gastroenterol Nurs, 37 (4), 280-7
    DOI 10.1097/SGA.0000000000000055, PubMed 25078042
13. Larsson G, Shenoy KT, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Bjune GA, Moum BA (2014)
    Faecal calprotectin levels differentiate intestinal from pulmonary tuberculosis: An observational study from Southern India
    United European Gastroenterol J, 2 (5), 397-405
    DOI 10.1177/2050640614546947, PubMed 25360318
14. Larsson G, Shenoy KT, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Bjune GA, Moum BA (2014)
    High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies
    Infect Dis (Lond), 47 (3), 137-43
    DOI 10.3109/00365548.2014.974206, PubMed 25522183
15. Larsson G, Shenoy T, Ramasubramanian R, Balakumaran LK, Småstuen MC, Bjune GA, Moum BA (2014)
    Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India
    World J Gastroenterol, 20 (17), 5017-24
    DOI 10.3748/wjg.v20.i17.5017, PubMed 24803814
16. Lohr JM, Aabakken L, Arnelo U, Gronroos J, Halttunen J, Hauge T, Jonas E, Kleveland PM, Schmidt PN, Swahn F, Saarela A, Toth E, Meisner S (2014)
    How to cannulate? A survey of the Scandinavian Association for Digestive Endoscopy (SADE) in 141 endoscopists (vol 47, pg 861, 2012)
    Scand. J. Gastroenterol., 49 (10), 1272
    DOI 10.3109/00365521.2014.937117
17. Monstad I, Hovde O, Solberg IC, A Moum B (2014)
    Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies
    Ann Gastroenterol, 27 (2), 95-104
    PubMed 24733679
18. Moum B, Hovde Ø, Høivik ML (2014)
    What have we learnt about the role of the environment and natural course of IBD in the new millennium? 20-year follow-up of the IBSEN cohort
    Dig Dis, 32 Suppl 1, 2-9
    DOI 10.1159/000367818, PubMed 25531347
19. Opheim R, Fagermoen MS, Jelsness-Jørgensen LP, Bernklev T, Moum B (2014)
    Sense of coherence in patients with inflammatory bowel disease
    Gastroenterol Res Pract, 2014, 989038
    DOI 10.1155/2014/989038, PubMed 24527028
20. Solberg IC, Cvancarova M, Vatn MH, Moum B, IBSEN Study Group (2014)
    Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's Disease (the IBSEN Study)
    Inflamm Bowel Dis, 20 (1), 60-8
    DOI 10.1097/01.MIB.0000436956.78220.67, PubMed 24280875

Publications 2013

1. Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF (2013)
   High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study
   Scand J Gastroenterol, 48 (11), 1286-93
   DOI 10.3109/00365521.2013.838605, PubMed 24073709
2. Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV, Epidemiology and Natural History Task Force of the International Organization of the Study of Inflammatory Bowel Disease (2013)
   A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease
   Inflamm Bowel Dis, 19 (9), 2001-10
   DOI 10.1097/MIB.0b013e318281f3bb, PubMed 23624887
3. Bodd M, Ráki M, Bergseng E, Jahnsen J, Lundin KE, Sollid LM (2013)
   Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease
   Eur J Immunol, 43 (10), 2605-12
   DOI 10.1002/eji.201343382, PubMed 23775608
4. Bonsaksen T, Fagermoen MS, Lerdal A (2013)
   Trajectories of self-efficacy in persons with chronic illness: an explorative longitudinal study
   Psychol Health, 29 (3), 350-64
   DOI 10.1080/08870446.2013.856432, PubMed 24219510
5. Bonsaksen T, Haukeland-Parker S, Lerdal A, Fagermoen MS (2013)
   A 1-year follow-up study exploring the associations between perception of illness and health-related quality of life in persons with chronic obstructive pulmonary disease
   Int J Chron Obstruct Pulmon Dis, 9, 41-50
   DOI 10.2147/COPD.S52700, PubMed 24379660
6. Bonsaksen T, Lerdal A, Fagermoen MS (2013)
   Trajectories of illness perceptions in persons with chronic illness: An explorative longitudinal study
   J Health Psychol, 20 (7), 942-53
   DOI 10.1177/1359105313504235, PubMed 24140616
7. Brottveit M, Beitnes AC, Tollefsen S, Bratlie JE, Jahnsen FL, Johansen FE, Sollid LM, Lundin KE (2013)
   Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity
   Am J Gastroenterol, 108 (5), 842-50
   DOI 10.1038/ajg.2013.91, PubMed 23588237
8. De Vos M, Louis EJ, Jahnsen J, Vandervoort JG, Noman M, Dewit O, Dʼhaens GR, Franchimont D, Baert FJ, Torp RA, Henriksen M, Potvin PM, Van Hootegem PP, Hindryckx PM, Moreels TG, Collard A, Karlsen LN, Kittang E, Lambrecht G, Grimstad T, Koch J, Lygren I, Coche JC, Mana F, Van Gossum A et al. (2013)
   Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy
   Inflamm Bowel Dis, 19 (10), 2111-7
   DOI 10.1097/MIB.0b013e31829b2a37, PubMed 23883959
9. Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, McKay C, Friess H, Manfredi R, Van Cutsem E, Löhr M, Segersvärd R, European Study Group on Cystic Tumours of the Pancreas (2013)
   European experts consensus statement on cystic tumours of the pancreas
   Dig Liver Dis, 45 (9), 703-11
   DOI 10.1016/j.dld.2013.01.010, PubMed 23415799
10. Finnes TE, Meyer HE, Falch JA, Medhus AW, Wentzel-Larsen T, Lofthus CM (2013)
    Secular reduction of excess mortality in hip fracture patients >85 years
    BMC Geriatr, 13, 25
    DOI 10.1186/1471-2318-13-25, PubMed 23496953
11. Hewitt S, Søvik TT, Aasheim ET, Kristinsson J, Jahnsen J, Birketvedt GS, Bøhmer T, Eriksen EF, Mala T (2013)
    Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch
    Obes Surg, 23 (3), 384-90
    DOI 10.1007/s11695-012-0772-3, PubMed 23015268
12. Hope H, Skar V, Sandstad O, Husebye E, Medhus AW (2013)
    Correction to: Small intestinal malabsorption in chronic alcoholism: a retrospective study of alcoholic patients by the ¹⁴C-D-xylose breath test
    Scand J Gastroenterol, 48 (10), 1231-1232
    DOI 10.3109/00365521.2013.825316, PubMed 28078905
13. Hovde Ø, Haugen Lie Ø, Johansson PA, Stubhaug Ø, Johnson E, Hofstad B, Hauge T (2013)
    Iatrogenic esophago-tracheal fistula: challenges in diagnosis and management
    World J Gastroenterol, 19 (4), 594-6
    DOI 10.3748/wjg.v19.i4.594, PubMed 23382643
14. Hovde Ø, Kempski-Monstad I, Småstuen MC, Solberg IC, Henriksen M, Jahnsen J, Stray N, Moum BA (2013)
    Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study
    Gut, 63 (5), 771-5
    DOI 10.1136/gutjnl-2013-304766, PubMed 23744613
15. Høivik ML, Reinisch W, Cvancarova M, Moum B, IBSEN study group (2013)
    Anaemia in inflammatory bowel disease: a population-based 10-year follow-up
    Aliment Pharmacol Ther, 39 (1), 69-76
    DOI 10.1111/apt.12541, PubMed 24172277
16. Jelsness-Jørgensen LP, Bernklev T, Moum B (2013)
    Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission
    Gastroenterol Res Pract, 2013, 620707
    DOI 10.1155/2013/620707, PubMed 23476638
17. Knatten CK, Avitsland TL, Medhus AW, Fjeld JG, Pripp AH, Emblem R, Bjørnland K (2013)
    Gastric emptying in children with gastroesophageal reflux and in healthy children
    J Pediatr Surg, 48 (9), 1856-61
    DOI 10.1016/j.jpedsurg.2013.03.076, PubMed 24074657
18. Nordby T, Ikdahl T, Bowitz Lothe IM, Fagerland MW, Heiberg T, Hauge T, Labori KJ, Buanes T (2013)
    Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma
    Pancreatology, 13 (2), 180-5
    DOI 10.1016/j.pan.2013.01.003, PubMed 23561977
19. Nordby T, Ikdahl T, Lothe IM, Ånonsen K, Hauge T, Edwin B, Line PD, Labori KJ, Buanes T (2013)
    Opportunities of improvement in the management of pancreatic and periampullary tumors
    Scand J Gastroenterol, 48 (5), 617-25
    DOI 10.3109/00365521.2013.781218, PubMed 23597153
20. Opheim R, Fagermoen MS, Bernklev T, Jelsness-Jorgensen LP, Moum B (2013)
    Fatigue interference with daily living among patients with inflammatory bowel disease
    Qual Life Res, 23 (2), 707-17
    DOI 10.1007/s11136-013-0508-4, PubMed 23975381
21. Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Nielsen OH, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H (2013)
    The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method
    Aliment Pharmacol Ther, 38 (9), 1109-18
    DOI 10.1111/apt.12493, PubMed 24099472
22. von Volkmann HL, Havre RF, Løberg EM, Haaland T, Immervoll H, Haukeland JW, Hausken T, Gilja OH (2013)
    Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease
    Med Ultrason, 15 (1), 16-22
    DOI 10.11152/mu.2013.2066.151.hlv1qmu2, PubMed 23486619

Publications 2012

1. Andenæs R, Fagermoen MS, Eide H, Lerdal A (2012)
   Changes in health-related quality of life in people with morbid obesity attending a learning and mastery course. A longitudinal study with 12-months follow-up
   Health Qual Life Outcomes, 10, 95
   DOI 10.1186/1477-7525-10-95, PubMed 22901031
2. Aouizerat BE, Gay CL, Lerdal A, Portillo CJ, Lee KA (2012)
   Lack of energy: an important and distinct component of HIV-related fatigue and daytime function
   J Pain Symptom Manage, 45 (2), 191-201
   DOI 10.1016/j.jpainsymman.2012.01.011, PubMed 22917712
3. Bakken LN, Kim HS, Finset A, Lerdal A (2012)
   Stroke patients' functions in personal activities of daily living in relation to sleep and socio-demographic and clinical variables in the acute phase after first-time stroke and at six months of follow-up
   J Clin Nurs, 21 (13-14), 1886-95
   DOI 10.1111/j.1365-2702.2011.04014.x, PubMed 22486783
4. Beitnes AC, Ráki M, Brottveit M, Lundin KE, Jahnsen FL, Sollid LM (2012)
   Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge
   PLoS One, 7 (3), e33556
   DOI 10.1371/journal.pone.0033556, PubMed 22438948
5. Bernstein CN, Loftus EV, Ng SC, Lakatos PL, Moum B, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) (2012)
   Hospitalisations and surgery in Crohn's disease
   Gut, 61 (4), 622-9
   DOI 10.1136/gutjnl-2011-301397, PubMed 22267595
6. Bonsaksen T, Lerdal A, Fagermoen MS (2012)
   Factors associated with self-efficacy in persons with chronic illness
   Scand J Psychol, 53 (4), 333-9
   DOI 10.1111/j.1467-9450.2012.00959.x, PubMed 22680700
7. Bonsakseni T, Lerdal A (2012)
   Relationships between physical activity, symptoms and quality of life among inpatients with severe mental illness
   Br. J. Occup. Ther., 75 (2), 69-75
   DOI 10.4276/030802212X13286281651036
8. Brottveit M, Vandvik PO, Wojniusz S, Løvik A, Lundin KE, Boye B (2012)
   Absence of somatization in non-coeliac gluten sensitivity
   Scand J Gastroenterol, 47 (7), 770-7
   DOI 10.3109/00365521.2012.679685, PubMed 22519894
9. Brun AC, Størdal K, Johannesdottir GB, Fossum V, Bentsen BS, Medhus AW (2012)
   Nissen fundoplication in children with cerebral palsy: influence on rate of gastric emptying and postprandial symptoms in relation to protein source in caloric liquid meals
   Clin Nutr, 32 (4), 619-23
   DOI 10.1016/j.clnu.2012.11.010, PubMed 23196118
10. Christiansen B, Borge L, Fagermoen MS (2012)
    Understanding everyday life of morbidly obese adults-habits and body image
    Int J Qual Stud Health Well-being, 7, 17255
    DOI 10.3402/qhw.v7i0.17255, PubMed 22866062
11. Hope H, Skar V, Sandstad O, Husebye E, Medhus AW (2012)
    Small intestinal malabsorption in chronic alcoholism: a retrospective study of alcoholic patients by the ¹⁴C-D-xylose breath test
    Scand J Gastroenterol, 47 (4), 428-34
    DOI 10.3109/00365521.2011.648951, PubMed 22229732
12. Hovde Ø, Moum BA (2012)
    Epidemiology and clinical course of Crohn's disease: results from observational studies
    World J Gastroenterol, 18 (15), 1723-31
    DOI 10.3748/wjg.v18.i15.1723, PubMed 22553396
13. Høivik ML, Moum B, Solberg IC, Henriksen M, Cvancarova M, Bernklev T, IBSEN Group (2012)
    Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
    Gut, 62 (3), 368-75
    DOI 10.1136/gutjnl-2012-302311, PubMed 22717453
14. Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum B (2012)
    Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease
    World J Gastroenterol, 18 (5), 445-52
    DOI 10.3748/wjg.v18.i5.445, PubMed 22346250
15. Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum B (2012)
    Is patient reported outcome (PRO) affected by different follow-up regimens in inflammatory bowel disease (IBD)? A one year prospective, longitudinal comparison of nurse-led versus conventional follow-up
    J Crohns Colitis, 6 (9), 887-94
    DOI 10.1016/j.crohns.2012.01.021, PubMed 22398072
16. Jelsness-Jørgensen LP, Bernklev T, Moum B (2012)
    Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report
    J Psychosom Res, 73 (6), 469-72
    DOI 10.1016/j.jpsychores.2012.08.009, PubMed 23148817
17. Johnson E, Kjellevold K, Johannessen HO, Drolsum A (2012)
    Long-term outcome after resection rectopexy for internal rectal intussusception
    ISRN Gastroenterol, 2012, 824671
    DOI 10.5402/2012/824671, PubMed 23346411
18. Jonasson C, Moum B, Bang C, Andersen KR, Hatlebakk JG (2012)
    Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD
    Aliment Pharmacol Ther, 35 (11), 1290-300
    DOI 10.1111/j.1365-2036.2012.05092.x, PubMed 22510027
19. Katsanos KH, Tatsioni A, Pedersen N, Shuhaibar M, Ramirez VH, Politi P, Ronnbrechts E, Pierik M, Clofent J, Beltrami M, Bodini P, Freitas J, Mouzas I, Fornaciari G, Moum B, Lakatos PL, Vermeire S, Langholz E, Odes S, Morain CO, Stockbrugger R, Munkholm P, Tsianos EV, EC-IBD Study Grp (2012)
    Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study (vol 5, pg 430, 2011)
    J. Crohns Colitis, 6 (1), 132-133
    DOI 10.1016/j.crohns.2011.11.023
20. Kolseth IB, Førland DT, Risøe PK, Flood-Kjeldsen S, Ågren J, Reseland JE, Lyngstadaas SP, Johnson E, Dahle MK (2012)
    Human monocyte responses to lipopolysaccharide and 9-cis retinoic acid after laparoscopic surgery for colon cancer
    Scand J Clin Lab Invest, 72 (8), 593-601
    DOI 10.3109/00365513.2012.721520, PubMed 23094762
21. Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Løberg EM, Haukeland JW (2012)
    Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver
    Scand J Gastroenterol, 48 (1), 93-100
    DOI 10.3109/00365521.2012.746389, PubMed 23205894
22. Larssen L, Hauge T, Medhus AW (2012)
    Stent treatment of malignant gastric outlet obstruction: the effect on rate of gastric emptying, symptoms, and survival
    Surg Endosc, 26 (10), 2955-60
    DOI 10.1007/s00464-012-2291-7, PubMed 22538695
23. Larssen L, Medhus AW, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde Ø, Tholfsen JK, Skreden K, Nesbakken A, Hauge T (2012)
    Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract
    Scand J Gastroenterol, 47 (12), 1505-14
    DOI 10.3109/00365521.2012.711854, PubMed 23046494
24. Lerdal A, Celius EH, Pedersen G (2012)
    Prescribed exercise: a prospective study of health-related quality of life and physical fitness among participants in an officially sponsored municipal physical training program
    J Phys Act Health, 10 (7), 1016-23
    DOI 10.1123/jpah.10.7.1016, PubMed 23136380
25. Löhr JM, Aabakken L, Arnelo U, Grönroos J, Halttunen J, Hauge T, Jonas E, Kleveland PM, Nordblad Schmidt P, Swahn F, Saarela A, Toth E, Meisner S (2012)
    How to cannulate? A survey of the Scandinavian Association for Digestive Endoscopy (SADE) in 141 endoscopists
    Scand J Gastroenterol, 47 (7), 861-9
    DOI 10.3109/00365521.2012.672588, PubMed 22512404
26. Nord R, Jerpseth H, Fagermoen MS (2012)
    The importance of a pilot study before validation of translated instruments
    Nordisk Sygeplejeforskning, 2 (1), 45-55
27. Opheim R, Bernklev T, Fagermoen MS, Cvancarova M, Moum B (2012)
    Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway
    Scand J Gastroenterol, 47 (12), 1436-47
    DOI 10.3109/00365521.2012.725092, PubMed 23003678
28. Rotegård AK, Fagermoen MS, Ruland CM (2012)
    Cancer patients' experiences of their personal strengths through illness and recovery
    Cancer Nurs, 35 (1), E8-E17
    DOI 10.1097/NCC.0b013e3182116497, PubMed 21558850
29. Rotegård AK, Fagermoen MS, Ruland CM (2012)
    Health assets in nursing documentation of cancer care
    NI 2012 (2012), 2012, 351
    PubMed 24199119
30. Solberg MT, Tandberg BS, Lerdal A (2012)
    Using a didactic model to improve patient observation skills in neonatal intensive care nurse trainees - a pilot study
    Intensive Crit Care Nurs, 28 (4), 208-14
    DOI 10.1016/j.iccn.2011.12.005, PubMed 22226799
31. Steindal SA, Ranhoff AH, Bredal IS, Sørbye LW, Lerdal A (2012)
    Last three days of life in the hospital: a comparison of symptoms, signs and treatments in the young old and the oldest old patients using the Resident assessment instrument for palliative care
    Int J Older People Nurs, 8 (3), 199-206
    DOI 10.1111/j.1748-3743.2012.00313.x, PubMed 22329702
32. Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
    Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
    Innate Immun, 19 (3), 290-7
    DOI 10.1177/1753425912461042, PubMed 23070967
33. Ånonsen KV (2012)
    ["Peak level" and "through level"]
    Tidsskr Nor Laegeforen, 132 (22), 2511; discussion 2511
    DOI 10.4045/tidsskr.12.1045, PubMed 23338035